Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 10;17(7):920.
doi: 10.3390/ph17070920.

Role of Dapagliflozin in Ischemic Preconditioning in Patients with Symptomatic Coronary Artery Disease-DAPA-IP Study Protocol

Marco Alexander Valverde Akamine  1 , Beatriz Moreira Ayub Ferreira Soares  1 , João Paulo Mota Telles  1 , Arthur Cicupira Rodrigues de Assis  1 , Gabriela Nicole Valverde Rodriguez  1 , Paulo Rogério Soares  1 , William Azem Chalela  1 , Thiago Luis Scudeler  1
Affiliations

Role of Dapagliflozin in Ischemic Preconditioning in Patients with Symptomatic Coronary Artery Disease-DAPA-IP Study Protocol

Marco Alexander Valverde Akamine et al. Pharmaceuticals (Basel). .

Abstract

Background: Ischemic preconditioning (IP) is a powerful cellular protection mechanism. The cellular pathways underlying IP are extremely complex and involve the participation of cell triggers, intracellular signaling pathways, and end-effectors. Experimental studies have shown that sodium-glucose transport protein 2 (SGLT2) inhibitors promote activation of 5'-adenosine monophosphate (AMP)-activated protein kinase (AMPK), the main regulator of adenosine 5'-triphosphate homeostasis and energy metabolism in the body. Despite its cardioprotective profile demonstrated by numerous clinical trials, the results of studies on the action of SGLT2 inhibitors in IP are scarce. This study will investigate the effects of dapagliflozin on IP in patients with coronary artery disease (CAD). Methods: The study will include 50 patients with multivessel CAD, ischemia documented by stress testing, and preserved left ventricular ejection fraction (LVEF). Patients will undergo four exercise tests, the first two with a time interval of 30 min between them after washout of cardiovascular or hypoglycemic medications and the last two after 7 days of dapagliflozin 10 mg once a day, also with a time interval of 30 min between them. Discussion: The role of SGLT2 inhibitors on IP is not clearly established. Several clinical trials have shown that SGLT2 inhibitors reduce the occurrence cardiovascular events, notably heart failure. However, such studies have not shown beneficial metabolic effects of SGLT2 inhibitors, such as reducing myocardial infarction or stroke. On the other hand, experimental studies with animal models have shown the beneficial effects of SGLT2 inhibitors on IP, a mechanism that confers cardiac and vascular protection from subsequent ischemia-reperfusion (IR) injury. This is the first clinical study to evaluate the effects of SGLT2 inhibitors on IP, which could result in an important advance in the treatment of patients with stable CAD.

Keywords: SGLT2 inhibitors; coronary artery disease; ischemic preconditioning; myocardial ischemia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Study design. Legend: CAD: coronary artery disease; ETT: exercise treadmill test; LVEF: left ventricular ejection fraction.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124–1136. doi: 10.1161/01.CIR.74.5.1124. - DOI - PubMed
    1. Waters D.D., McCans J.L., Crean P.A. Serial exercise testing in patients with effort angina: Variable tolerance, fixed threshold. J. Am. Coll. Cardiol. 1985;6:1011–1015. doi: 10.1016/S0735-1097(85)80302-8. - DOI - PubMed
    1. MacAlpin R.N., Kattus A.A. Adaptation to exercise in angina pectoris. The electrocardiogram during treadmill walking and coronary angiographic findings. Circulation. 1966;33:183–201. doi: 10.1161/01.CIR.33.2.183. - DOI - PubMed
    1. Ylitalo K., Jama L., Raatikainen P., Peuhkurinen K. Adaptation to myocardial ischemia during repeated dynamic exercise in relation to findings at cardiac catheterization. Am. Heart J. 1996;131:689–697. doi: 10.1016/S0002-8703(96)90272-0. - DOI - PubMed
    1. Jaffe M.D., Quinn N.K. Warm-up phenomenon in angina pectoris. Lancet. 1980;2:934–936. doi: 10.1016/S0140-6736(80)92101-7. - DOI - PubMed

Grants and funding

This research received no external funding.

LinkOut - more resources

  NODES
chat 1
twitter 2